There are 1105 resources available
LBA5 - Zongertinib in patients with HER2-mutant NSCLC: Updated analysis of beamion LUNG-1
Presenter: Noboru Yamamoto
Session: Proffered Paper session: Thoracic malignancies
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Incorporating immunotherapy in gastrointestinal (GI) cancer
Resources:
Webcast
59O - A first-in-human, phase I study of BPI-371153, a novel small-molecule PD-L1 inhibitor, in advanced solid tumors or recurrent/refractory (r/r) lymphoma
Presenter: Jianliang Yang
Session: Proffered Paper session: Developmental and precision medicine
Resources:
Abstract
Slides
Webcast
LBA6 - PACIFIC-5: A phase III study of consolidation durvalumab (D) in patients (pts) with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy (cCRT or sCRT)
Presenter: Yi-Long Wu
Session: Proffered Paper session: Thoracic malignancies
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session: Breast cancer
Resources:
Webcast
Invited Discussant 478O and 59O
Presenter: Stefan Symeonides
Session: Proffered Paper session: Developmental and precision medicine
Resources:
Slides
Webcast
LBA7 - Efficacy and safety of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously-treated EGFR-mutated advanced non-small cell lung cancer (NSCLC): A pooled analysis of TROPION-Lung01 and TROPION-Lung05
Presenter: Myung-Ju Ahn
Session: Proffered Paper session: Thoracic malignancies
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session: Developmental and precision medicine
Resources:
Webcast
Invited Discussant LBA5, LBA6 and LBA7
Presenter: Sanjay Popat
Session: Proffered Paper session: Thoracic malignancies
Resources:
Slides
Webcast
Q&A and discussion
Session: Proffered Paper session: Thoracic malignancies
Resources:
Webcast